The CHMP renders a positive opinion recommending approval for MRK's Keytruda for the first-line treatment of malignant ...

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...

I expect 10 companies to announce their annual increases in the second half of November. Click here for a detailed analysis.

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update. Sichuan Kelun-Biotech ...